These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22464795)

  • 1. Mobile safe injecting facilities in Barcelona and Berlin.
    Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
    Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
    [No Abstract]   [Full Text] [Related]  

  • 2. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
    Wenger LD; Arreola SG; Kral AH
    Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nurses in the drug abuse field: accepting and empathic attitude is a prerequisite].
    Thate S; Leicht A; Dettmer K
    Pflege Z; 2009 Oct; 62(10):593-6. PubMed ID: 19883027
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of harm reduction programmes in Russia.
    Lancet; 2009 Oct; 374(9697):1213. PubMed ID: 19819371
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.
    Milloy MJ; Wood E
    Addiction; 2009 Apr; 104(4):620-1. PubMed ID: 19335659
    [No Abstract]   [Full Text] [Related]  

  • 7. Harm reduction--from a conceptual framework to practical experience: the example of Germany.
    Michels II; Stöver H
    Subst Use Misuse; 2012; 47(8-9):910-22. PubMed ID: 22676562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical condition facing needle exchange programs: the politics of science.
    Sherman SG
    Subst Use Misuse; 2006; 41(6-7):827-9. PubMed ID: 16809169
    [No Abstract]   [Full Text] [Related]  

  • 9. "Harm reduction--coming of age": a local movement with global impact.
    Stimson GV
    Int J Drug Policy; 2007 Mar; 18(2):67-9. PubMed ID: 17689346
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
    Arnaud S; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary health care for people who inject drugs in low and middle income countries.
    Myers BJ
    Int J Drug Policy; 2012 Mar; 23(2):105-6. PubMed ID: 22030256
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injecting drug users' experiences of targeted harm reduction in the Russian Federation.
    Power R; Nozhkina N; Kanarsky I
    Drug Alcohol Rev; 2005 Jan; 24(1):69-77. PubMed ID: 16191724
    [No Abstract]   [Full Text] [Related]  

  • 14. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 15. Attendance at supervised injecting facilities and use of detoxification services.
    Wood E; Tyndall MW; Zhang R; Stoltz JA; Lai C; Montaner JS; Kerr T
    N Engl J Med; 2006 Jun; 354(23):2512-4. PubMed ID: 16760459
    [No Abstract]   [Full Text] [Related]  

  • 16. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 17. Safer injecting facilities in Vancouver: considering issues beyond potential use.
    Fry CL
    CMAJ; 2003 Oct; 169(8):777-8. PubMed ID: 14557315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
    Wodak A; Cooney A
    Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.